Video Gallery

Welcome Remarks
	Welcome Remarks Dr. Jian-Xiang Wang

Opening Remarks
	Opening Remarks Dr. Jie Jin

Basic Science of MPN
	Clinical significance of genetic stratification of MPN patients Dr. Robert Kralovics
	Molecular Mechanism of MPN Development by Mutant Calreticulin Dr. Marito Araki
	The Cytogenetics in MPN Dr. Jian Huang
	Refined Assay for Highly Sensitive Measurement of JAK2V617F Allele Burden Dr. Chih-Cheng Chen

Hot Topic of MPN
	The evolving potential for MDM2 antagonism in PV Dr. John Mascarenhas
	New Therapies for MPNs Dr. Ruben Mesa

Asian MPN Session
	ET in China Dr. Lei Zhang
	MPN: Experience from China Dr. Zhi-Jian Xiao
	Clinical and Molecular Features of Taiwanese Patients with WHO-Defined -Essential Thrombocythemia and Pre-Myelofibrosis with Thrombocytosis Dr. Lee-Yung Shih
	Clinical features of ET and PET-MF in Japan Dr. Kazuya Shimoda

IFN Renassiance
	Should phlebotomy only be standard treatment for low risk patients with PV or should they receive interferon? Dr. Richard Silver
	A revisit of PROUD/CONTI Study Dr. Srdan Verstovsek
	Combining interferon and JAK2 inhibition for MPN eradication Dr. Jean-Jacques Kiladjian
	Interferon Renaissance in Hepatitis B Therapy Dr. Pei-Jer Chen

Panel Discussion
	Panel discussion Dr. Jean-Jacques Kiladjian & Dr. Srdan Verstovsek
	Closing Remarks Dr. Zhi-Jian Xiao
	Remark on 4^th MPN Asia in Korea Dr. Jong-Jin Seo